Acadia Pharmaceuticals | ACAD - Stock


Acadia Pharmaceuticals reported $29.1M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Acadia Pharmaceuticals USD 29.1M 2.97M Sep/2025
ALKERMES USD 191M 927K Sep/2025
Alnylam Pharmaceuticals USD 75.38M 3.7M Sep/2025
Biogen USD 2.21B 64.9M Sep/2025
BioMarin Pharmaceutical USD 1.38B 42M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Corcept Therapeutics USD 12.35M 73K Sep/2025
Cytokinetics USD 0 0 Dec/2023
Eisai JPY 227.32B 11.41B Jun/2025
Eli Lilly USD 12.18B 1.17B Sep/2025
Incyte USD 83.45M 24K Sep/2025
J&J USD 14.15B 734M Sep/2025
Moderna USD 332M 92M Sep/2025
Neurocrine Biosciences USD 69.3M 12.4M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
PTC Therapeutics USD 52.69M 18.63M Sep/2025
Sarepta Therapeutics USD 1.08B 83.13M Sep/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
Vertex Pharmaceuticals USD 1.63B 127.5M Sep/2025